Skip to content
MS
Single-pathway Pathway metabolite unreviewed

Bilirubin diglucuronide

0
Pathways
0
Categories
0
As substrate
0
As product

Reactions involving Bilirubin diglucuronide

Every recorded step where this molecule takes part

Showing all 1 reactions.

Recent literature

Europe PMC · from cache · sorted by publication date

  1. 1
    Multimodal optical system for quantitative discrimination of bilirubin species.

    Zwicky J, Fehr D, Albert I, Lehmann S, Witthauer L, Bonmarin M. · 2026-02-18

    cited 1× open access unreviewed
  2. 2
    Risk Assessment for Drug-Induced Hyperbilirubinemia: A Mechanistic Approach.

    Kumar R, Kumar A, Alam A, Mundkur Y, Wingrove J. · 2026-03-01

    cited 1× open access unreviewed
  3. 3
  4. 4
  5. 5
    Heme in Bacterial Pathogenesis and as an Antimicrobial Target.

    Chen PY, Skaar EP. · 2025-11-17

    cited 6× open access unreviewed
  6. 6
    Stimulation of Skin Pigmentation with UVR Is a Risk Factor for Cholelithiasis.

    Pavel S, Riley PA. · 2025-08-25

    open access unreviewed
  7. 7
    Insights from Metabolomics Profiling of MSUD in Pediatrics Toward Disease Progression.

    Alotaibi AZ, AlMalki RH, Sebaa R, Al Mogren M, Alanazi M, Sumaily KM, Alodaib A, Mujamammi AH, Jacob M, Sabi … · 2025-10-04

    open access unreviewed
  8. 8
    OATP1B1/1B3 deficiency exacerbates hyperbilirubinemia in erythropoietic protoporphyria.

    Gu R, Qin FY, Wang L, Zhang J, Emerson J, Ma Q, Lu J, Anderson KE, Wang J, Ma X. · 2025-05-27

    cited 2× open access unreviewed
  9. 9
    Biliary Microbial Community and Metabolic Potential in Patients with Multiple Common Bile Duct Stones.

    Xia T, Feng S, Zou Z, Zhou J, Cai X, Ye J, Dai C. · 2025-05-07

    open access unreviewed
  10. 10
    Study of Minor Chromophores in Biological Tissues by Diffuse Optical Spectroscopy (Review).

    Bylinskaya KA, Perekatova VV, Turchin IV. · 2025-02-28

    cited 2× open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.